Company Filing History:
Years Active: 2025
Title: Susana Del Rio Gancedo: Innovator in Pharmaceutical Chemistry
Introduction
Susana Del Rio Gancedo is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of KRas G12C inhibitors. With a total of 2 patents, his work is paving the way for advancements in cancer treatment.
Latest Patents
His latest patents focus on crystalline forms of a KRas G12C inhibitor. The inventions relate to crystalline forms of the KRas G12C inhibitor 2-[(2S)-4-[7-(8-chloro-1-naphthyl)-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-1-(2-fluoroprop-2-enoyl)piperazin-2-yl]acetonitrile. These patents also cover pharmaceutical compositions comprising the crystalline forms, processes for preparing them, and methods of use.
Career Highlights
Susana is currently employed at Mirati Therapeutics, Inc., where he continues to innovate in the pharmaceutical sector. His work is crucial in the ongoing battle against cancer, particularly in targeting specific mutations.
Collaborations
He collaborates with talented coworkers such as Patricia Andres and Samuel Andrew, contributing to a dynamic research environment that fosters innovation.
Conclusion
Susana Del Rio Gancedo's contributions to pharmaceutical chemistry, particularly through his patents on KRas G12C inhibitors, highlight his role as a key innovator in the field. His work at Mirati Therapeutics, Inc. continues to impact cancer treatment positively.